Crystal Amber Fund Announces Share Buyback Programme
The investment fund announces a share buyback programme to repurchase up to £3 million or 1.8 million of its own shares.
The investment fund announces a share buyback programme to repurchase up to £3 million or 1.8 million of its own shares.
The investment fund reported a slight increase in NAV per share, but faced an overall loss and decreased total NAV. A successful exit and regulatory approval for a key holding were offset by portfolio concentration risks.
The investment fund is hosting an online investor presentation for Morphic Medical, a medical device company it owns a majority stake in.
The medical device company will be hosting an investor presentation, providing an opportunity for existing and potential shareholders to learn more about the business.
The medical device company has appointed a new Chief Financial Officer with extensive experience in the industry.
The medical device company has received regulatory approval to sell its innovative obesity and diabetes treatment in the UK market.
The medical device company has appointed a new Chief Executive with experience in the bariatric endoscopy space.
The investment fund announces a share buyback programme to repurchase up to £2.5 million of its own shares.
The major shareholder of this investment fund has increased its stake, but no further details are provided.
The investment manager of the Crystal Amber Fund has sold a portion of its shareholding in the company.